TriniTuner.com | Latest Event:
Moderator: 3ne2nr Mods
hover11 wrote:Where the ppl that saying open the country FB_IMG_1624653212951.jpeg
Habit7 wrote:Dohplaydat wrote:Cases don't matter, every country has different testing criteria, deaths are a better metric. And I like how suddenly Belize and Surinam conveniently ended up the Caribbean.
Given those trends you posted, we are still almost last and probably be 2nd or 3rd to last in Caricom by end of August. And you still proud?
All these places except us had open borders for almost a year too.
Cases are no better or worse metric than death. You trust other countries' reporting, countries who up until late last year still had to send samples to CARPHA in TT to be tested, to incorrectly say we are the worst, but now you trust them over us?
So Guyana in the Caribbean but not Caricom members like Belize and Suriname? Then tell them to give back their donations that India gave to Caricom then.
Stop trying to find down de ting nah.
hover11 wrote:Where the ppl that saying open the country FB_IMG_1624653212951.jpeg
Mmoney607 wrote:hover11 wrote:Where the ppl that saying open the country FB_IMG_1624653212951.jpeg
DMan7. Where yuh boy?
Where the it doing dung crew?
Where the imaginary vaccine gathering didn't cause a spike crew?
Where the under 200 crew?
DMan7 wrote:Mmoney607 wrote:hover11 wrote:Where the ppl that saying open the country FB_IMG_1624653212951.jpeg
DMan7. Where yuh boy?
Where the it doing dung crew?
Where the imaginary vaccine gathering didn't cause a spike crew?
Where the under 200 crew?
That's just an anomaly, doh study it too hard before yuh buss yuh head. Cases going down, next week will continue to be in the low 200's and high 100's consistently which means we're still on track to open up soon.
AlphaMan wrote:If SEA could happen next week then we safe to open up.
If you get Corona and dead your fault.
TIME TO OPEN UP!!
AlphaMan wrote:If SEA could happen next week then we safe to open up.
If you get Corona and dead your fault.
TIME TO OPEN UP!!
daring dragoon wrote:AlphaMan wrote:If SEA could happen next week then we safe to open up.
If you get Corona and dead your fault.
TIME TO OPEN UP!!
exactly, open the cuntry and wear yuh mask and wash yuh hands, business allow only a certain amount of persons inside, social distance and vaccinate.
Dohplaydat wrote:paid_influencer wrote:Habit7 wrote:There are no vaccines to ramp up anything. Just annoying ppl lamenting for vaccines that are not available not just to TT but to most of the developing world.
yea those ppl need to shut up. We get it, the inactivated virus vaccines aren't as good at preventing transmission and won't allow us to reopen in the same way America and the UK are reopening. We understand that. But it will help save lives today and it is an important part of the integrated strategy of dealing with the virus.
Keep your mask on, keep social distancing, do not lime or attend gatherings even after being vaccinated. The vaccine will help, but you still need to do all those things if we want to keep the virus under control.
I have not said otherwise, take the Sinopharm as it will save your life. Just please know we are still far from normal, I honestly think we'll need many covid measures still well into 2022.
bluefete wrote:I will just quietly leave this here.
https://www.msn.com/en-us/money/other/c ... r-BB1gCGwD
China Sinovac Shot Seen Highly Effective in Real World Study
Bloomberg News 5/12/2021
(Bloomberg) -- Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.
Indonesia tracked 128,290 health workers in capital city Jakarta from January to March and found that the vaccine protected 98% of them from death and 96% from hospitalization as soon as seven days after the second dose, Pandji Dhewantara, a Health Ministry official who oversaw the study, said in a Wednesday press conference.
Dhewantara also said that 94% of the workers had been protected against symptomatic infection -- an extraordinary result that goes beyond what was measured in the shot’s numerous clinical trials. Health Minister Budi Gunadi Sadikin earlier revealed a smaller version of the study involving 25,374 people in a Tuesday interview with Bloomberg that had the same effectiveness data for hospitalization and infection. Protection against death was 100% in the smaller group.
“We see a very, very drastic drop,” in hospitalizations and deaths among medical workers, Sadikin said. It’s not known what strain of the coronavirus Sinovac’s shot worked against in Indonesia, but the country has not flagged any major outbreaks driven by variants of concern.
The data adds to signs out of Brazil that the Sinovac shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over data transparency. Results from its biggest Phase III trial in Brazil put the shot known as CoronaVac’s efficacy at just above 50%, the lowest among all first-generation Covid vaccines.
A spokesman for Sinovac in Beijing said the company cannot comment on the Indonesian study until it acquires more details.
The Indonesian study compared vaccinated against non-vaccinated people to derive the estimated effectiveness. The median age of the participants is 31 years old.
In a separate interview with Bloomberg Tuesday, Sinovac’s chief executive officer Yin Weidong defended the disparity in clinical data around the shot, and said there was growing evidence CoronaVac is performing better when applied in the real world.
Places That Use Sinovac’s Shot
East Asia & Pacific
South & Central Asia
Sub-Saharan
Africa
Middle East & North Africa
Central & Eastern Europe
Latin America & Caribbean
China
Hong Kong
Laos
Cambodia
Malaysia
Thailand
Indonesia
Philippines
Pakistan
Sudan
Zimbabwe
Guinea
Benin
Equatorial Guinea
Somalia
Egypt
Tunisia
Turkey
Ukraine
Azerbaijan
Hungary
Bosnia and Herzegovina
Moldova
Albania
Brazil
Mexico
Colombia
Chile
Ecuador
Dominican Republic
Paraguay
El Salvador
Uruguay
But the real-world examples also show that the Sinovac shot’s ability to quell outbreaks requires the vast majority of people to be vaccinated, a scenario that developing countries with poor health infrastructure and limited access to shots cannot reach quickly. In the Indonesian health worker study, and another in a Brazilian town of 45,000 people called Serrana, nearly 100% of people studied were fully vaccinated, with serious illness and deaths dropping after they were inoculated.
In contrast, Chile saw a resurgent outbreak after vaccinating over a third of the population of 19 million -- one of the fastest rates in the world, but not fast enough to stop the spread of the aggressive variant sweeping Latin America.
“The earliest group of people vaccinated in Chile are old people. Less than 15 million of doses given to Chile means only 7 million people can get our shots. That equals to only 36% of a population of 19 million,” said Yin. “It’s normal that the country sees a resurgence of infections as social activities increase among the younger people who are mainly not inoculated.”
Among people vaccinated with CoronaVac in Chile, 89% were protected from serious Covid that requires intensive care, said Yin.
The vaccine’s protection is likely to vary from place to place due to virus variants, but Sinovac’s shot appears to be holding up well against the new mutations of concern, he said.
A key question for all Covid vaccines is whether they can prevent or deter actual transmission of the virus. Yin said Tuesday that Sinovac does not yet know if its shot -- a traditional inactivated vaccine -- can stop or reduce the virus from being contracted in the first place, but the fact it is preventing serious illness and death is more important.
The mRNA shot developed by BioNTech SE and Pfizer Inc. has been shown to be over 90% effective in preventing transmission in Israel.
While non-mRNA vaccines are unlikely to be that effective in preventing transmission, the growing body of evidence that Sinovac’s shot works is a boon to China’s mission of supplying the developing world in a bid to increase its influence and standing. It’s also somewhat of a vindication amid criticism that Chinese vaccine developers disclosed less data and were less transparent about severe adverse events compared with western companies.
“The results from real world application and the scientific data we have from clinical trials will allow the world to judge our vaccine comprehensively,” said Yin. “We encourage our partners and governments in countries where our vaccine is being used to release such data as soon as possible.”
Indonesia was one of the earliest countries to place its bets on a Chinese vaccine. In January, President Joko Widodo became the first major world leader to receive the Sinovac shot in a bid to quell skepticism at home and abroad. Since then, Southeast Asia’s largest economy has administered more than 22 million doses, mostly Sinovac, as it seeks to reach herd immunity for its 270-million strong population by year-end.
“The minimum efficacy rate should be above 50%, so beyond that, the best vaccine is the one you can get as soon as possible, as every shot given can prevent deaths,” Health Minister Sadikin said. “It isn’t only about getting the highest efficacy rate, but inoculating people quickly.”
While neighboring Malaysia and Thailand are seeing a resurgence in cases, Indonesia’s rate of new infections and deaths has stabilized since a January peak. But with its massive population still mostly unprotected, the upcoming Eid holiday could cause cases to rebound by as much as 60% as people gather with family and travel home despite government restrictions, Sadikin warned.
Helen Petousis-Harris, a vaccinologist at the University of Auckland, said that the ability of vaccines to control a disease can be higher in the real world than when measured in clinical trials.
“In my experience, we often fail to predict the overall impact of vaccines, something that can only be seen in the real world after widespread use,” she said. “Reducing the bulk of disease is not only essential to save lives but also to reduce the chances of problematic variants appearing.”
(Updates with detail from expanded study from Indonesia.)
For more articles like this, please visit us at bloomberg.com
©2021 Bloomberg L.P.
DMan7 wrote:daring dragoon wrote:AlphaMan wrote:If SEA could happen next week then we safe to open up.
If you get Corona and dead your fault.
TIME TO OPEN UP!!
exactly, open the cuntry and wear yuh mask and wash yuh hands, business allow only a certain amount of persons inside, social distance and vaccinate.
Did you purposefully left out the vaccinate option?
AlphaMan wrote:bluefete wrote:I will just quietly leave this here.
https://www.msn.com/en-us/money/other/c ... r-BB1gCGwD
China Sinovac Shot Seen Highly Effective in Real World Study
Bloomberg News 5/12/2021
(Bloomberg) -- Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.
Indonesia tracked 128,290 health workers in capital city Jakarta from January to March and found that the vaccine protected 98% of them from death and 96% from hospitalization as soon as seven days after the second dose, Pandji Dhewantara, a Health Ministry official who oversaw the study, said in a Wednesday press conference.
Dhewantara also said that 94% of the workers had been protected against symptomatic infection -- an extraordinary result that goes beyond what was measured in the shot’s numerous clinical trials. Health Minister Budi Gunadi Sadikin earlier revealed a smaller version of the study involving 25,374 people in a Tuesday interview with Bloomberg that had the same effectiveness data for hospitalization and infection. Protection against death was 100% in the smaller group.
“We see a very, very drastic drop,” in hospitalizations and deaths among medical workers, Sadikin said. It’s not known what strain of the coronavirus Sinovac’s shot worked against in Indonesia, but the country has not flagged any major outbreaks driven by variants of concern.
The data adds to signs out of Brazil that the Sinovac shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over data transparency. Results from its biggest Phase III trial in Brazil put the shot known as CoronaVac’s efficacy at just above 50%, the lowest among all first-generation Covid vaccines.
A spokesman for Sinovac in Beijing said the company cannot comment on the Indonesian study until it acquires more details.
The Indonesian study compared vaccinated against non-vaccinated people to derive the estimated effectiveness. The median age of the participants is 31 years old.
In a separate interview with Bloomberg Tuesday, Sinovac’s chief executive officer Yin Weidong defended the disparity in clinical data around the shot, and said there was growing evidence CoronaVac is performing better when applied in the real world.
Places That Use Sinovac’s Shot
East Asia & Pacific
South & Central Asia
Sub-Saharan
Africa
Middle East & North Africa
Central & Eastern Europe
Latin America & Caribbean
China
Hong Kong
Laos
Cambodia
Malaysia
Thailand
Indonesia
Philippines
Pakistan
Sudan
Zimbabwe
Guinea
Benin
Equatorial Guinea
Somalia
Egypt
Tunisia
Turkey
Ukraine
Azerbaijan
Hungary
Bosnia and Herzegovina
Moldova
Albania
Brazil
Mexico
Colombia
Chile
Ecuador
Dominican Republic
Paraguay
El Salvador
Uruguay
But the real-world examples also show that the Sinovac shot’s ability to quell outbreaks requires the vast majority of people to be vaccinated, a scenario that developing countries with poor health infrastructure and limited access to shots cannot reach quickly. In the Indonesian health worker study, and another in a Brazilian town of 45,000 people called Serrana, nearly 100% of people studied were fully vaccinated, with serious illness and deaths dropping after they were inoculated.
In contrast, Chile saw a resurgent outbreak after vaccinating over a third of the population of 19 million -- one of the fastest rates in the world, but not fast enough to stop the spread of the aggressive variant sweeping Latin America.
“The earliest group of people vaccinated in Chile are old people. Less than 15 million of doses given to Chile means only 7 million people can get our shots. That equals to only 36% of a population of 19 million,” said Yin. “It’s normal that the country sees a resurgence of infections as social activities increase among the younger people who are mainly not inoculated.”
Among people vaccinated with CoronaVac in Chile, 89% were protected from serious Covid that requires intensive care, said Yin.
The vaccine’s protection is likely to vary from place to place due to virus variants, but Sinovac’s shot appears to be holding up well against the new mutations of concern, he said.
A key question for all Covid vaccines is whether they can prevent or deter actual transmission of the virus. Yin said Tuesday that Sinovac does not yet know if its shot -- a traditional inactivated vaccine -- can stop or reduce the virus from being contracted in the first place, but the fact it is preventing serious illness and death is more important.
The mRNA shot developed by BioNTech SE and Pfizer Inc. has been shown to be over 90% effective in preventing transmission in Israel.
While non-mRNA vaccines are unlikely to be that effective in preventing transmission, the growing body of evidence that Sinovac’s shot works is a boon to China’s mission of supplying the developing world in a bid to increase its influence and standing. It’s also somewhat of a vindication amid criticism that Chinese vaccine developers disclosed less data and were less transparent about severe adverse events compared with western companies.
“The results from real world application and the scientific data we have from clinical trials will allow the world to judge our vaccine comprehensively,” said Yin. “We encourage our partners and governments in countries where our vaccine is being used to release such data as soon as possible.”
Indonesia was one of the earliest countries to place its bets on a Chinese vaccine. In January, President Joko Widodo became the first major world leader to receive the Sinovac shot in a bid to quell skepticism at home and abroad. Since then, Southeast Asia’s largest economy has administered more than 22 million doses, mostly Sinovac, as it seeks to reach herd immunity for its 270-million strong population by year-end.
“The minimum efficacy rate should be above 50%, so beyond that, the best vaccine is the one you can get as soon as possible, as every shot given can prevent deaths,” Health Minister Sadikin said. “It isn’t only about getting the highest efficacy rate, but inoculating people quickly.”
While neighboring Malaysia and Thailand are seeing a resurgence in cases, Indonesia’s rate of new infections and deaths has stabilized since a January peak. But with its massive population still mostly unprotected, the upcoming Eid holiday could cause cases to rebound by as much as 60% as people gather with family and travel home despite government restrictions, Sadikin warned.
Helen Petousis-Harris, a vaccinologist at the University of Auckland, said that the ability of vaccines to control a disease can be higher in the real world than when measured in clinical trials.
“In my experience, we often fail to predict the overall impact of vaccines, something that can only be seen in the real world after widespread use,” she said. “Reducing the bulk of disease is not only essential to save lives but also to reduce the chances of problematic variants appearing.”
(Updates with detail from expanded study from Indonesia.)
For more articles like this, please visit us at bloomberg.com2021 Bloomberg L.P.
First World Countries say they aint want Sinopharm vaccinated persons in their country so it aint matter how much studies prove it works.
Its a useless vaccine that this government paying top tax payers dollars for.
bluefete wrote:Hover11: It is simple geo-politics and economics at play here. Who controls the media controls the news that you get and what you believe.
There is a global big pharma battle between the Chinese, Americans and Europeans for market share. And if dis-information has to be part of that - so be it.
So some of the people who got the vaccines will not transmit but could still get Covid-19. That makes no sense to me. The purpose of a vaccine is to PREVENT. But, okay.
Alphaman: Do you not recognize how the world is being chained up over this? If the Sinovac vacine is good, why would Canada and the Europeans not want to use it or accept people who have been vaccinated with it?
So because the Europeans and Americans say "it is a useless vaccine" - that makes it so. Again, okay.
Makes perfect sense to me.
bluefete wrote:Hover11: It is simple geo-politics and economics at play here. Who controls the media controls the news that you get and what you believe.
There is a global big pharma battle between the Chinese, Americans and Europeans for market share. And if dis-information has to be part of that - so be it.
So some of the people who got the vaccines will not transmit but could still get Covid-19. That makes no sense to me. The purpose of a vaccine is to PREVENT. But, okay.
Alphaman: Do you not recognize how the world is being chained up over this? If the Sinovac vacine is good, why would Canada and the Europeans not want to use it or accept people who have been vaccinated with it?
So because the Europeans and Americans say "it is a useless vaccine" - that makes it so. Again, okay.
Makes perfect sense to me.
Habit7 wrote:Dohplaydat wrote:Habit7 wrote:
The struggle is real. We need to open back up soon as possible so that ppl can work and not need welfare. But if we open up too much, ppl will get sick and die and ppl will call the doctors murderers. You cant please everybody.
Government dug a stupid hole for itself by lazily managing the covid situation and not providing proper relief and fast enough vaccination.
When they open up, no matter if we wait 3 months from cases will spike. We are in a sheit situation thanks to rediculously poor governance.
How much time I have to remind you. YOU were saying in March the govt was too stringent, now you are saying that they are too lazy? I can quote you if you forget.
You are the perfect example of not being able to please everybody because you don't criticise on a consistent principle.
And this not "fast enough vaccination." Vaccines from where?
The govt managed covid excellently from March 2020 to March 2021. We had very small numbers for our size, they won an election based on it touting their management of covid. Commendations from Oxford, US govt and WHO. Then we experienced the same spike most countries in the world did, suddenly it is "poor governance." Sometimes I wish we could ship out some of allyuh mouthers on your own island and see how you will fair. Because it seems like you stayed in a Holiday Inn once and now you know everything thing in law, medicine and engineering. And when I point out your errors, that doesn't count.
hover11 wrote:https://newsday.co.tt/2021/06/25/teenage-girl-dies-from-covid19-death-toll-nears-800/
Please note a healthy 16 year old girl died today with no comorbidities and we honestly thinking of reopening schools madness when ppl under 18 cannot take the vaccine
MaxPower wrote:How healthy is healthy exactly?
Healthy healthy?
Kinda healthy?
Generally assumably healthy?
I feel good healthy?
Be safe out there everyone.
Gladiator wrote:You really are the king of the cacaholes to believe that fable that you type there....
AlphaMan wrote:hover11 wrote:https://newsday.co.tt/2021/06/25/teenage-girl-dies-from-covid19-death-toll-nears-800/
Please note a healthy 16 year old girl died today with no comorbidities and we honestly thinking of reopening schools madness when ppl under 18 cannot take the vaccine
If SEA could take place the its time to open back up.
Only games this government playing.
hover11 wrote:https://newsday.co.tt/2021/06/25/teenage-girl-dies-from-covid19-death-toll-nears-800/
Please note a healthy 16 year old girl died today with no comorbidities and we honestly thinking of reopening schools madness when ppl under 18 cannot take the vaccine
Return to “Ole talk and more Ole talk”
Users browsing this forum: Dizzy28, Google [Bot] and 97 guests
